Record 10 Brand-Name Drugs Win China Bulk-Buying Bids

Multinational drugmakers are returning to China’s centralized procurement program after rule changes gave originator medicines a second path to selection, though stronger price pressure still looms

Raccontata dacaixinglobal.com